Rodolfo Castilla will be based in Uruguay and will oversee the group’s independent advisor network across Latin America.
CCR Monthly Approval Report – March 2020
Hermes led with five mutual funds approved, followed by Barings and DWS with two products, and Invesco, Federated, EDM and JP Morgan with one mutual fund each.
Equity fund flows remained positive in March as Brazil looked past Covid-19
Equity funds had net inflow of BRL 8.3 billion in March and drew in BRL 45 billion for the quarter.
Net inflows stayed positive for Brazilian mutual funds in shaky February
For the fifth month in a row, the Equity class had the best result for the month. After raising BRL12.8 billion in February, the class shows net inflow of BRL36.3 billion in 2020.
Aviva hires Capital Strategies to distribute into Brazil and Uruguay
The deal completes Aviva’s geographical coverage of Iberia and Latin America, complementing an existing partnership with Excel Capital, which represents Aviva in institutional markets in Chile, Peru and Colombia.
CCR Monthly Approval Report – February 2020
A total of 12 products were added in the month from nine different asset managers: Allianz, JP Morgan, Sycomore, Vanguard, Ardian, Clayton, Dubilier & Rice, New Mountain, Newbury Partners, and StepStone.
Abrupt exit for Itaú Corpbanca CEO
Manuel Olivares Rossetti stepped aside at the end of January 2020 after a barely a year on the job. He had joined the firm from BBVA Chile.
Equity funds in Brazil enjoyed banner year in 2019, shattering records
With net funding of BRL 17 billion in December, the equity class ended the year with its best annual performance and the industry's largest net inflow at BRL 86 billion, tripling its 2018 result.
CCR Monthly Approval Report – January 2020
Lazard, Credicorp Capital, Franklin Templeton, Pictet, Aditya Birla Sun Life, Altamar, Golden Gate, CarVal Investors, Golub, Kayne Anderson and Monarch were the managers registering products in January 2020.
JPM adds its name to list of managers with Afore-ready products
The fund – JPM US Select Equity – aims to achieve a return in excess of the US equity market by investing primarily in US companies that are selected by a research-driven investment process based on the fundamental analysis.






